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Summary  Epstein—Barr  virus  (EBV)  is  a  common  infection  that  affects  95%  of
adults  worldwide  at  some  point  during  life.  It  is  usually  asymptomatic  or  causes
a  self-limiting  clinical  syndrome  known  as  infectious  mononucleosis.  It  rarely  causes
complications.  Here,  we  present  a  case  of  a  healthy  21-year-old  female  college
student  who  suffered  from  severe  pancreatitis  and  life-threatening  autoimmune
hemolytic  anemia  in  association  with  EBV  infection,  and  we  also  discuss  the  com-
mon  presentation  of  EBV  infection  and  the  diagnosis  and  treatment  of  simple  and
complicated  EBV  infection.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.∗ Corresponding author at: Division of Hospital Medicine, 4th
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BV  infection  is  common  and  affects  more  than
5% of  adults  worldwide  at  some  point  during
ife. The  clinical  syndrome  associated  with  EBV  is
nown as  infectious  mononucleosis  and  commonly
resents with  fever,  pharyngitis  and  lymphadeno-
athy [1].  EBV  infection  rarely  causes  infectious
nces. Published by Elsevier Limited. All rights reserved.
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Domplicated  Epstein—Barr  virus  infection  
ononucleosis  if  the  primary  infection  is  acquired
n childhood.  However,  more  than  30%  of  adoles-
ents and  adults  with  primary  EBV  infection  develop
nfectious  mononucleosis  [2], which  is character-
zed initially  by  sore-throat-like  symptoms  that  are
ften followed  by  palatal  petechiae,  transamini-
is, thrombocytopenia,  splenomegaly,  and  hep-
tomegaly  [1,2].  It  usually  resolves  over  a  period
f weeks  or  months  with  no  sequelae;  however,  it
an occasionally  be  complicated  by  a  wide  variety
f neurologic,  hematologic,  hepatic,  respiratory,
nd psychological  complications  [3].  Infectious
ononucleosis  commonly  occurs  in  children,  young
dults and  persons  who  live  in  densely  populated
uildings, such  as  dorms  [2]. Immunocompromised
atients  have  a  high  risk  of  developing  infectious
ononucleosis.  EBV  carriers  shed  virus  particles
rom their  salivary  glands  throughout  life,  but  the
ate of  shedding  is  highest  during  the  ﬁrst  year
ollowing primary  infection  [2].  EBV  spreads  via
odily ﬂuids,  most  commonly  through  direct  con-
act with  saliva.  Although  intimate  sexual  contact
s most  commonly  associated  with  EBV  infection
n young  adults,  it  can  be  transmitted  through
asual contact,  such  as  a  handshake;  sharing  tow-
ls, toothbrushes,  food  or  utensils;  and  general
roximity, with  a  carrier  or  infected  individual.
ase report
 21-year-old  female  college  student  with  a history
f migraine  presented  with  complaints  of  malaise,
ever, epigastric  pain  radiating  to  the  back,  nausea,
omiting  and  sore  throat  that  had  been  present  for
hree days  prior  to  admission.  The  patient  denied
rior  exposure  to  hazardous  chemicals,  unexpected
eight loss,  hemorrhagic  or  thrombotic  events,
isual disturbance,  neurological  symptoms,  skin
ash, high  risk  sexual  behavior  and  intravenous  drug
se. She  admitted  to  occasional  drinking;  however,
er last  drink  was  10  days  prior  to  admission.  The
atient  reported  regular  menstrual  periods  lasting
rom  2 to  3  days  without  excessive  bleeding.  One  of
he patient’s  siblings  reported  symptoms  consistent
ith  upper  respiratory  tract  infection  two  weeks
rior to  the  patient’s  admission.  The  patient  denied
ntimate  contact  with  any  companion  in  her  recent
ast.  Her  initial  physical  examination  revealed  no
oxicity, female  appearance,  temperature  of  99 ◦F,
lood pressure  of  110/65  mmHg,  a  mildly  injected
harynx, small  bilateral  shoddy  non-tender  cervical
ymph  nodes,  and  abdominal  tenderness  in  the  right
pper quadrant  and  epigastrium.
Laboratory  data  revealed  a  total  white  blood
ell count  of  7.9  cells/L  (70%  neutrophils,  7%
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typical  lymphocytes),  hemoglobin  of  3.8  g/dl,
latelet  count  of  157  k/L,  aspartate  aminotrans-
erase of  98  U/l,  alanine  aminotransferase  of
2 U/l,  total  bilirubin  of  2.4  mg/dl,  and  lipase
f 4301  U/l.  Computerized  tomography  of  the
bdomen  revealed  ﬁndings  consistent  with  acute
ancreatitis,  namely  pancreatic  edema,  peripan-
reatic  stranding,  periportal  lucency  with  mild
ericholecystic  edema  and  mild  splenomegaly.
The disease  included  in  the  differential  diagnosis
f anemia  were  intravascular  hemolysis,  microan-
iopathic  hemolytic  anemia  due  to  disseminated
ntravascular  coagulation  (DIC),  anemia  cause  by
cute and  chronic  blood  loss  resulting  from  pep-
ic ulcers  and  possible  menorrhagia.  Although  the
atient did  not  report  a history  of  excessive  men-
trual blood  loss,  menorrhagia  was  included  in
he differential  diagnoses  due  her  age.  Acute  and
hronic blood  loss  and  DIC  were  ruled  out  based
n the  laboratory  studies  and  the  patient’s  history
nd physical  examination.  The  laboratory  studies
evealed  evidence  of  acute  intravascular  hemoly-
is. The  peripheral  blood  smear  demonstrated  mild
hrombocytopenia  marked  by  anemia  with  aniso-
ytosis  and  reticulocytosis.  The  serological  studies
Table  1)  revealed  acute  EBV  infection,  which  could
e associated  with  multi-system  involvement  in  this
atient.
The patient’s  acute  autoimmune  hemolytic  ane-
ia (AIHA)  was  treated  with  1 mg/kg  prednisone
ulse therapy  for  ﬁve  days,  and  the  dose  was
hen tapered  over  the  following  two  weeks.  She
lso required  blood  transfusions  during  the  initial
hase of  hospitalization.  The  pulse  steroid  therapy
alted  the  hemolysis,  as  indicated  by  stabilization
f hemoglobin,  increased  haptoglobin  and  normal-
zation of  bilirubin  by  discharge  on  the  9th  day
f hospitalization.  Her  hemoglobin  was  9.2  g/dl  on
ay 7  and  9.4  g/dl  on  day  9 of  hospitalization.  At
he three  week  outpatient  follow-up  appointment,
er hemoglobin  was  10.2  g/dl.  Pancreatitis  was
lso successfully  treated  with  conservative  man-
gement.  As  her  abdominal  symptoms  completely
esolved and  her  lipase  level  gradually  decreased
ver the  period  of  hospitalization,  radiological  con-
rmation  of  pancreatic  inﬂammation  resolution
as deemed  unnecessary.  The  patient  made  a full
ecovery  with  no  sequelae.
iscussionn  this  case,  the  diagnosis  of  infectious  mononu-
leosis was  based  on  the  patient’s  history  and
hysical and  laboratory  ﬁndings.  The  patient  was
ositive for  EBV-IgM  antibody  and  negative  for
100  
Table  1  Summary  of  serological  studies.
Test  Results
Heterophile  antibody
(Monospot)
Positive
EBV-IgM  antibody  3  (>1.1  =  acute
infection)
Positive
EBV-IgG  antibody Negative
Acute  hepatitis  A,  B  &  C  serology  Non-reactive
HIV-1  &  2  antibody  Non-reactive
Flow  cytometry  No  PNH  clone
Parvovirus-B19  IgM  Negative
Parvovirus-B19  IgG  Positive
Parvovirus-B19  PCR  Not  detected
Mycoplasma-IgM/IgG  Negative
ANA  screen  Negative
Anti-smooth  muscle  IgG
antibody
Negative
Alpha-1  Antitrypsin  Negative
Tissue  transglutaminase
antibody
Negative
Ceruloplasmin  Negative
Direct  antiglobin  test  (Coomb’s
test)
Positive
Respiratory  viral  panela Negative
Cytomegalovirus  IgM/IgG Negative
EBV, Epstein—Barr virus; HIV, human immunodeﬁciency virus;
Ig, immunoglobulin; PCR, polymerase chain reaction; PNH,
paroxysmal nocturnal hematurea.
a Tested viruses (PCR) include Inﬂuenza A, Inﬂuenza A sub-
type H1, Inﬂuenza A subtype H3, Inﬂuenza B, Respiratory
Syncytial Virus, Human Metapneumovirus, Rhinovirus, and
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EBV-IgG  antibody.  She  lacked  any  other  rele-
vant infections,  including  human  immunodeﬁciency
virus (Table  1).  According  to  the  American  College
of Gastroenterology  guidelines,  the  presence  of  two
of the  following  three  characteristics  is  sufﬁcient
for the  diagnosis  of  acute  pancreatitis:  (1)  abdomi-
nal pain,  (2)  serum  lipase  level  higher  than  three
times the  upper  normal  limit,  and  (3)  radiologi-
cal evidence  of  acute  pancreatitis  [4]. The  patient
had all  three  of  these  characteristics,  with  a  serum
lipase  level  more  than  10  times  the  upper  normal
limit. Therefore,  further  testing  was  not  necessary
to conﬁrm  the  diagnosis  of  acute  pancreatitis.  The
source of  the  patient’s  infection  was  unclear.  Her
sibling,  who  had  a  recent  self-limiting  upper  respi-
ratory  infection,  was  considered  a  potential  source.
EBV can  be  transmitted  through  casual  contact,
such as  a  handshake;  sharing  towels,  toothbrushes,
food or  utensils;  and  general  proximity,  with  an
infected  or  carrier  individual.  Unreported  exposure
of the  patient  to  EBV  at  her  college  was  also  con-
sidered  but  could  not  be  conﬁrmed.  Primary  EBV
e
s
c
ES.  Singh,  P.  Khosla
nfection  is  common  among  college  students  in  the
nited States.  A  monthly  serological  surveillance
tudy revealed  that  EBV  developed  in  more  than  12%
f initially  seronegative  students  over  the  course  of
hree years  [5].
EBV  is  diagnosed  based  on  patient  history  and
hysical and  laboratory  studies.  The  presence  of
ore than  10%  atypical  lymphocytes  on  peripheral
lood ﬁlm  helps  narrow  the  differential  diagno-
is to  EBV  infection  with  75%  sensitivity  and  92%
peciﬁcity  [6]. Monospot  eterophile  antibody  tests
ighly speciﬁc  for  EBV,  with  nearly  100%  speciﬁcity.
t is  mainly  used  to  conﬁrm  EBV  infection  because
ts low  sensitivity  makes  it  unsuitable  as  screening
est [6]. Clinicians  should  be  highly  suspicious  of
uman immunodeﬁciency  virus  infection  in  patients
eing examined  for  possible  EBV  infection  because
uman  immunodeﬁciency  virus  can  present  with
imilar symptoms  to  those  of  EBV  and  results  in
 positive  Monospot  test  due  to  cross-reactivity  of
BV antibodies  with  human  immunodeﬁciency  virus
ntibodies  [7]. The  possibility  of  human  immuno-
eﬁciency virus  infection  is also  important  because
ongenital  and  acquired  immune  suppression  are
mportant  risk  factors  for  EBV  infection.  Immuno-
uppressive  therapy  for  a  variety  of  conditions
redisposes patients  to  EBV  infection  [8].  Poly-
erase  chain  reaction  can  be  used  to  conﬁrm  EBV
nfection  if  other  tests  are  equivocal  or  a  false  pos-
tive test  result  is  suspected  [6].  Our  patient  was
egative  for  human  immunodeﬁciency  virus.
Acute EBV  infection  causes  AIHA  in  approx-
mately 3%  of patients  [3]. Acute  pancreatitis
ssociated with  EBV  is  even  rarer.  Only  nine  case
eports  of acute  pancreatitis  associated  with  EBV
ave been  reported  in  the  literature  [9—11], and
ost  of  those  cases  were  reported  in  children
r adolescents  [9]. We  could  not  locate  any  case
eport in  the  PubMed  database  of  EBV  infection
ssociated with  both  AIHA  and  acute  pancreatitis
n a healthy  adult.  Our  patient  was  a  previously
ealthy young  female  who  presented  with  the  very
are combination  of AIHA  and  acute  pancreatitis.
EBV infection  is  treated  with  supportive  care;
owever, corticosteroids  decrease  the  duration
nd severity  of  complications,  such  as  airway
bstruction, immune-mediated  anemia  and  throm-
ocytopenia.  A  trial  of  corticosteroids  may  be
elpful  for  patients  experiencing  life-threatening
omplications  [3,6]. For  our  patient,  a ﬁve-day
igh-dose pulse  corticosteroid  therapy  followed  by
 two  week  taper  resulted  in  complete  recov-
ry. However,  there  is  insufﬁcient  evidence  to
upport  the  use  of  corticosteroids  for  symptom
ontrol in cases  of  uncomplicated  infection  [6].
mpirical evidence  from  case  reports  and  small
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ase  series  suggest  that  acyclovir  or  ganciclovir
ould be  beneﬁcial  in  the  treatment  of  compli-
ated infections  [3,6]. Our  patient  responded  well
o the  corticosteroid  therapy;  therefore,  we  did  not
dminister  antiviral  treatment.  Our  main  goal  was
o control  hemolysis.  Corticosteroids  are  the  drug
f choice  for  the  treatment  of  acute  AIHA,  regard-
ess of  its  etiology  [12].  Therefore,  it  is unclear  if
teroid therapy  had  any  role  in  controlling  the  EBV
nfection  in  our  patient.
unding
o  funding  sources.
onﬂict of interest
one  declared.
thical approval
ot  required.
cknowledgments
e  are  grateful  to  Navsheen  Grewal,  MHA  student
t University  of  Illinois  at  Chicago,  for  helping  us
erform the  literature  search  to  obtain  full  text
rticles for  the  background  information  for  this
anuscript.
[
Available  online  at  www
ScienceD101
eferences
[1] Grose C. The many faces of infectious mononucleosis: the
spectrum of Epstein—Barr virus infection in children. Pedi-
atr Rev 1985;7:35—44.
[2] Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl
J Med 2010;362:1993—2000.
[3] Jenson HB. Acute complications of Epstein—Barr virus infec-
tious mononucleosis. Curr Opin Pediatr 2000;12:263—8.
[4] Tenner S, Baillie J, DeWitt J, Vege SS. American College
of Gastroenterology. American College of Gastroenterology
guideline: management of acute pancreatitis. Am J Gas-
troenterol 2013;108(September (9)):1400—15.
[5] Balfour Jr HH, Odumade OA, Schmeling DO, Mullan BD,
Ed JA, Jennifer A. Behavioral, virologic, and immunologic
factors associated with acquisition and severity of primary
Epstein—Barr virus infection in university students. J Infect
Dis 2013;207(January (1)):80—8.
[6] Vouloumanou EK, Rafailidis PI, Falagas ME. Current diagno-
sis and management of infectious mononucleosis. Curr Opin
Hematol 2012;19:14—20.
[7] Walensky RP, Rosenberg ES, Ferraro MJ, Losina E, Walker
BD, Freedberg KA. Investigation of primary human immu-
nodeﬁciency virus infection in patients who test positive
for heterophile antibody. Clin Infect Dis 2001;33:570—2.
[8] Bargallo A, Carrion S, Domenech E, Arevalo JA, Manosa,
Cabre E, et al. Infectious mononucleosis in patients with
inﬂammatory bowel disease under treatment with azathio-
prine. Gastroenterol Hepatol 2008;31(5):289—92.
[9] Khawcharoenporn T, Lau WK, Chokrungvaranon N.
Epstein—Barr virus infection with acute pancreatitis. Int J
Infect Dis 2008;12(March (2)):227—9.
10] Marín García D, Ruiz Serrato A, Reina González AM, García
Ordón˜ez MA. Pancreatitis aguda asociada a infección por el
virus de EpsteinBarr. Semergen 2012;38:476—7.
11] López-Ibán˜ez MC, Moreno-Conde M, Gallego-De-la-
Sacristana-López-Serrano Á, García-Catalán-Gallego F,
Villar-Ráez A. Acute pancreatitis as atypical manifestation
of Epstein—Barr virus infection. Rev Esp Enferm Dig
2013;105(August (7)):437—8.12] Zanella A, Barcellini W. Treatment of autoimmune
hemolytic anemias. Haematologica 2014;99(October (10)):
1547—54.
.sciencedirect.com
irect
